NeonMind Biosciences Inc.
NMDBF · OTC
11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $36 | $774 | $1 | $108 |
| Short-Term Investments | $34 | $194 | $0 | $0 |
| Receivables | $58 | $105 | $20 | $0 |
| Inventory | $0 | $0 | $17 | $0 |
| Other Curr. Assets | $0 | $0 | $58 | $0 |
| Total Curr. Assets | $129 | $1,279 | $95 | $108 |
| Property Plant & Equip (Net) | $0 | $3 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $28 | $0 |
| Long-Term Investments | $0 | $0 | $86 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $58 | $0 | $0 |
| Total NC Assets | $0 | $60 | $115 | $32 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $129 | $1,339 | $210 | $140 |
| Liabilities | – | – | – | – |
| Payables | $677 | $582 | $180 | $21 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $17 | $116 | $1,247 |
| Total Curr. Liab. | $684 | $599 | $296 | $1,268 |
| LT Debt | $847 | $450 | $691 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $847 | $450 | $691 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,531 | $1,049 | $987 | $1,268 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $8,380 | $7,801 | $1,779 | $237 |
| Retained Earnings | -$15,123 | -$13,089 | -$5,881 | -$1,365 |
| AOCI | $5,299 | $5,557 | $3,325 | $0 |
| Other Equity | $43 | $21 | $0 | $0 |
| Total Equity | -$1,402 | $290 | -$777 | -$1,128 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $129 | $1,339 | $210 | $140 |
| Net Debt | $811 | -$324 | $690 | -$108 |